LOUISIANA STATE UNIVERSITY – SHELBY MACRAE, MD
Advancing multidisciplinary research and specialized clinical care for bronchiectasis and nontuberculous mycobacterial (NTM) lung disease through clinical trials, registry initiatives, health equity programs, and patient-centered care across the Gulf South.
SHELBY MACRAE, MD
Principal Investigator
LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER
Institution
BRONCHIECTASIS & NTM PROGRAM
Research / Clinical Program
Project Overview
Loma Linda University Health is a 1,046-bed academic medical center with a strong focus on pulmonary, critical care, sleep, and hyperbaric medicine research. The division actively conducts clinical research led by faculty, fellows, and residents, while participating in industry-sponsored and NIH-funded clinical trials related to pulmonary disease and advanced lung care.
Project Summary
Under the leadership of Twinkle Chandak, MD, FCCP, the center conducts multidisciplinary research focused on bronchiectasis, NTM disease, pulmonary rehabilitation, pulmonary hypertension, and critical care outcomes. The program emphasizes collaborative care, airway clearance education, clinical trials, and evidence-based strategies to improve long-term patient outcomes.
Project Goals
- Improve care and outcomes for patients with NTM and bronchiectasis
- Expand airway clearance education and quality improvement initiatives
- Advance multidisciplinary pulmonary and critical care research
Impact
The center’s research and clinical initiatives are helping improve patient education, reduce hospitalizations, enhance sputum conversion outcomes, and expand specialized pulmonary care services. Ongoing collaborations and research efforts continue to support innovation in bronchiectasis and NTM management.
Advancing Research. Improving Lives.
Supporting innovative pulmonary research that drives better outcomes for patients with chronic lung disease and NTM-related conditions.
Twinkle Chandak, MD
Email: tchandak@llu.edu
Phone: (201) 757-8325
Project Overview
The NTM Research Consortium funds early-stage research to accelerate advances in the diagnosis, treatment, and cure of NTM lung disease.